Uncategorized

syndicate global distribution

Nicopure Labs Announces Partnership with Vapоr Ltd.

TAMPA, Fla. (Jan. 16, 2018) – Nicopure Labs, LLC, the leading manufacturer of American-made e-liquids, announces its partnership with Vapоr Ltd. in the Bulgarian market. Following a review of business in Bulgaria, Nicopure Labs has made the decision to appoint Vapоr Ltd., a distributor for Bulgaria, effective immediately. “In the last [...]

syndicate global distribution

Nicopure Labs Announces Partnership with Replace Smoke

TAMPA, Fla. (Nov. 29, 2017) – Nicopure Labs, LLC, the leading manufacturer of American-made e-liquids, announces its partnership with Replace Smoke in the Greek market. Following a review of business in Greece, Nicopure Labs has made the decision to appoint Replace Smoke a distributor for Greece effective immediately. “In the last [...]

syndicate global distribution

Nicopure Labs Appoints New Chief Marketing Officer

TAMPA, FL-Nicopure Labs, LLC, the leading manufacturer of American-made e-liquid brands Halo, eVo, and Purity, announces the appointment of Neil Calvesbert to Chief Marketing Officer. With more than 25 years of experience successfully executing global brand visions and strategies, building content-driven digital marketing programs, and leading global teams and departments [...]

compliance

FDA Deeming Rule Q&A with Patricia Kovacevic

In this webinar, recorded on August 11, 2016, Patricia Kovacevic answered questions live about the FDA Deeming Rule. @7:25 FDA Inspections @13:33 Mixing Liquids/Re-Labeling Products in Stores @17:15 Sampling @24:25 Online Sales, Advertising, and Apps @32:39 Update on Litigation @42:16 Consumers Handling Products Prior to Purchase @49:28 Repackaging Products About Nicopure Labs Nicopure Labs is a premium American [...]

Patricia Kovacevic to Speak at Upcoming Conferences

Nicopure Labs General Counsel and Chief Compliance Officer Patricia Kovacevic will be speaking at the Vapor Technology Association's upcoming conference on June 7th: VAPE & THE FDA: Understand It. Manage It. Patricia will also lead a panel of experts to discuss Substantial Equivalence under the FDA Deeming Rule at TMA’s June 9th conference .